Contractor
TG THERAPEUTICS INC
MORRISVILLE, NC
- UEI
- JKPZKD19WMD7
- Parent UEI
- JKPZKD19WMD7
- Resolved by
- uei
- Confidence
- 1.000
Obligated to date
$01
Awards
1
Agencies served
1
Active from Apr 17, 2024 to Sep 2, 2026.
Sign in to watchRecent awards
| Award | Agency | Place | First action | Current value |
|---|---|---|---|---|
| 36E79724D0024 NEW AWARD FOR UBLITUXIMAB-XIIY 150MG/6ML INJECTION (ANTI-CD20 ANTIBODIES WITH TG THERAPEUTICS. PERIOD OF PERFORMANCE JUNE 17, 2024 - JUNE 16, 2025 WITH FOUR ONE-YEAR OPTIONS. | Department of Veterans Affairs | — | Apr 17, 2024 | — |
Sources and method
Figures on this page are computed from public federal award records. Numbers are never estimated or generated; where a figure is withheld, the reason is stated rather than filled in.
Totals sum obligations across every award attributed to this contractor. Obligations are cumulative funding actions, not the value of work delivered.
- 1Awards are attributed by Unique Entity Identifier JKPZKD19WMD7, the government's own recipient identifier, not by name matching.
- 2Award records from USAspending.gov, last refreshed Sep 12, 2026.